[1] World Health Organization: Tumours of the ovary,
Kurman RJ ed: WHO Classification of Tumours of Female Reproductive Organs.p11-86,
IARC,
Lyon,
2014
[2] Clement PB YR.
Surface epithelial-stromal tumors; general features,
serous tumors,
and mucinous tumors,
endometrioid,
clear cell,
transitional,
squamous,
rare,
undifferentiated,
and mixed cell types.
Atlas of Gynecologic Surgical Pathology 3rd ed.
London: Elsevier,
2014: p343-407.
[3] Seidman JD et al.
Surface Epithelial Tumors of the Ovary.
Kurman RJ ed.
Blaunstein's Pathology of the Female Genital Tract 6th ed.
ed.
New York: Springer,
2010: p 679-784.
[4]Stevens SK,
Hricak H,
Stern JL.
Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T.
Radiology.
1991;181(2):481-8.
[5] Tanaka YO,
S.
O,
Satoh T,
et al.
Solid non-invasive ovarian masses on MR: Histopathology and a diagnostic approach.
European Journal of Radiology. 2011;80:e91-e7
[6] Tanaka YO,
Okada S,
Yagi T,
et al.
MRI of endometriotic cysts in association with ovarian carcinoma.
AJR Am J Roentgenol.
2010;194(2):355-61.
[7] Tanaka YO,
Yoshizako T,
Nishida M,
Yamaguchi M,
Sugimura K,
Itai Y.
Ovarian carcinoma in patients with endometriosis: MR imaging findings.
AJR Am J Roentgenol.
2000;175(5):1423-30.
[8] Tanase Y,
Kawaguchi R,
Takahama J,
Kobayashi H.
Factors that Differentiate between Endometriosis-associated Ovarian Cancer and Benign Ovarian Endometriosis with Mural Nodules.
Magn Reson Med Sci.
2017.
[9] Manabe T,
Hirose Y,
Kiryuu T,
Koudo H,
Hoshi H.
Magnetic resonance imaging of endometrial cancer and clear cell cancer.
J Comput Assist Tomogr.
2007;31(2):229-35.
[10] Matsuoka Y,
Ohtomo K,
Araki T,
Kojima K,
Yoshikawa W,
Fuwa S.
MR imaging of clear cell carcinoma of the ovary.
Eur Radiol.
2001;11(6):946-51.
[11] Ma FH,
Qiang JW,
Zhang GF,
Li HM,
Cai SQ,
Rao YM.
Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma.
J Ovarian Res.
2016;9(1):40.
[12] Zhang P,
Cui Y,
Li W,
Ren G,
Chu C,
Wu X.
Diagnostic accuracy of diffusion-weighted imaging with conventional MR imaging for differentiating complex solid and cystic ovarian tumors at 1.5T.
World J Surg Oncol.
2012;10:237.
[13] Mukuda N,
Fujii S,
Inoue C,
et al.
Apparent diffusion coefficient (ADC) measurement in ovarian tumor: Effect of region-of-interest methods on ADC values and diagnostic ability.
J Magn Reson Imaging.
2016;43(3):720-5.
[14] Zhao SH,
Qiang JW,
Zhang GF,
et al.
Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation.
Eur Radiol.
2014;24(9):2292-9.
[15] Fujii S,
Kakite S,
Nishihara K,
et al.
Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions.
J Magn Reson Imaging.
2008;28(5):1149-56.
[16] Thomassin-Naggara I,
Darai E,
Cuenod CA,
et al.
Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses.
Eur Radiol.
2009;19(6):1544-52.
[17] Takeuchi M,
Matsuzaki K,
Nishitani H.
Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses.
J Comput Assist Tomogr.
2010;34(2):173-6.